TRV-2026-1949Version 1 · Certified

Written 2026-10-19 22:03:41 UTC · current record

Reason for this version

Certified into the record

Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-1949
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-10-19T22:03:41.647587Z
status: published
lens: trace
sector: science
headline: A Retrospective Benchmark of Quantitative Antimicrobial Peptide Activity Prediction Tools
dek: Antimicrobial peptides (AMPs) are critical candidates for addressing the global antibiotic resistance crisis. AI-driven quantitative models capable of directly predicting peptide antimicrobial activity, specifically minimum inhibitory concentration (MIC), are gaining scientific prominence by providing precise guidance for the rational design of AMPs. To assess their real-world, out-of-the-box performance, we conducted a retrospective benchmark of 10 publicly released quantitative AMP prediction tools spanning cl…
gain_title: Selected tools kept useful relative-ranking and virtual-screening enrichment ability, so they can work as early-stage filters when screening peptide candidates.
problem_title: Most publicly released tools gave poor absolute MIC predictions and transferred badly to an external dataset, so they cannot replace experimental measurement.
trace_subject: Performance of released quantitative AI tools for predicting antimicrobial peptide MIC
gain_reading: Selected tools kept useful relative-ranking and virtual-screening enrichment ability, so they can work as early-stage filters when screening peptide candidates.
gain_evidence: selected tools retained useful relative-ranking and enrichment capabilities
problem_reading: Most publicly released tools gave poor absolute MIC predictions and transferred badly to an external dataset, so they cannot replace experimental measurement.
problem_evidence: Most released tools exhibited poor absolute MIC regression and limited transferability to the external benchmark
quick_read: Researchers benchmarked 10 publicly released quantitative prediction tools for antimicrobial peptides, covering both classical machine learning and deep learning. They tested the tools on an external dataset and on reconstructed native datasets, looking at absolute MIC regression, reproducibility, ranking ability and virtual-screening enrichment.

The results matter because antibiotic resistance drives interest in designing peptides computationally, and overreliance on weak predictors could misdirect lab effort. The study supports using the tools as early filters rather than as precise stand-ins for lab MIC measurements. The abstract does not say which tools performed best or how much lab work they could save.
limitation: The tools were assessed retrospectively, and most showed limited transferability to the external benchmark, so their predictions cannot stand in for experimental MIC measurements.
tag: Dual reading
key_points: Ten publicly released quantitative AMP prediction tools were tested out of the box, spanning classical machine learning and deep learning. | Most tools showed poor absolute MIC regression and limited transfer to the external benchmark. | Some tools retained useful relative ranking and enrichment performance in virtual screening. | Implementation-level reproducibility differed markedly among the released tools. | Prediction errors were systematically linked to peptide residue composition, and predicted activity ranges were generally compressed.
rundown: The evaluation used a retrospective design with an external dataset plus reconstructed native datasets. It assessed several dimensions: absolute MIC regression, retrospective reproducibility, directional prediction patterns, ranking capability and virtual-screening enrichment.

Error-stratified analyses found systematic associations between prediction errors and peptide residue composition. The predicted activity range was also generally compressed, so the models tended to squeeze the spread of true potency values.

The authors conclude that these accessible tools have practical performance boundaries. They recommend treating them as early-stage screening filters, not as precise substitutes for experimental MIC measurements, in the effort against antibiotic resistance.
sources:
- peer_reviewed | Small Methods | https://doi.org/10.1002/smtd.71137 | 2026-10-15
prev: 0000000000000000000000000000000000000000000000000000000000000000
sha256
67248c584d42c0298a93aa0a7b09eefa5aff3d198bedb10b69df3b92604b2a8e
previous
0000000000000000000000000000000000000000000000000000000000000000
Verify this record
How to verify without trusting this page

Fetch the canonical text of any version from /api/record/TRV-2026-1949 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.